Kura Oncology, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 10.26 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 912.74M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Details
| Name | Kura Oncology, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 260 |
| Founded | 2014 |
| Ceo | Troy Wilson |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US50127T1097 |
| Cusip | 50127T109 |
| Cik | 0001422143 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Troy Edward Wilson J.D., Ph.D. | Chairman, Chief Executive Officer and President |
| Kathleen Ford | Chief Operating Officer |
| Brian T. Powl M.B.A., M.S. | Chief Commercial Officer |
| Jennifer Fulk | Chief Financial Officer |
| Thomas Doyle | Senior Vice President of Finance and Accounting |
| Dr. Francis J. Burrows Ph.D. | Chief Scientific Officer |
| Greg Mann | Senior Vice President of Investor Relations and Corporate Affairs |
| Teresa Brophy Bair Esq., J.D. | Chief Legal Officer and Corporate Secretary |
| Dr. Roger Bakale Ph.D. | Senior Vice President of Manufacturing and Supply Chain |
| Dr. Mollie Leoni M.D. | Chief Medical Officer |
Contact
| Address | 4930 Directors Place, Suite 500, San Diego, California 92121, United States |
| Phone | 858 500 8800 |
| Website | https://www.kuraoncology.com |